The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
International Journal of Cancer · 2025-04 · 156 (7) · 1336-1346
DOI: 10.1002/ijc.35278 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 17.12.2024. Verfasst von Adalberto M Filho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 1007-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: World Health Organization.
Abstract (Originalsprache)
The data sources and methods used to develop global cancer incidence and mortality statistics—the GLOBOCAN estimates—for the year 2022 are documented in this article, alongside a brief overview of the global cancer burden. The estimates, made available in 185 countries or territories worldwide for 36 cancer sites by sex and age, are based on the best available local data sources, namely population‐based cancer registries (for incidence) and national vital statistics (for mortality). In males, lung cancer was the most commonly diagnosed cancer worldwide in 2022 (1.57 million new cases [95% UI: 1.56–1.58]), followed by prostate cancer (1.47 million [1.46–1.48]). With 2.30 million (2.28–2.30) new cases estimated in 2022, breast cancer was the most diagnosed cancer in females, followed by lung cancer (0.91 million [0.90–0.91 million]) and cervical cancer (0.66 million [0.66–0.67]). The most common causes of cancer death in males and females were lung cancer (1.23 million [1.22–1.24]) and breast cancer (0.67 million [0.66–0.67]), respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
- The African Cancer Registry Network, Oxford, UK.
- Nuffield Department of Population Health, University of Oxford, Oxford, UK.
ORCID-Profile: Adalberto M Filho, Ariana Znaor, Freddie Bray
Förderung
- World Health Organization
Zitieren
APA
Filho, A. M., Laversanne, M., Ferlay, J., Colombet, M., Piñeros, M., Znaor, A., Parkin, D. M., Soerjomataram, I., & Bray, F. (2025). The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. International Journal of Cancer, 156(7), 1336-1346. https://doi.org/10.1002/ijc.35278
Vancouver
Filho AM, Laversanne M, Ferlay J, Colombet M, Piñeros M, Znaor A, et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. International Journal of Cancer. 2025;156(7):1336-1346. doi:10.1002/ijc.35278
BibTeX
@article{Filho2025,
author = {Filho, Adalberto M and Laversanne, Mathieu and Ferlay, Jacques and Colombet, Murielle and Piñeros, Marion and Znaor, Ariana and Parkin, Donald M and Soerjomataram, Isabelle and Bray, Freddie},
title = {The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide},
journal = {International Journal of Cancer},
year = {2025},
volume = {156},
number = {7},
pages = {1336--1346},
doi = {10.1002/ijc.35278}
}
EUVIMED